REDX — Redx Pharma Balance Sheet
0.000.00%
Last trade - 00:00- £46.68m
- £46.27m
- £4.20m
Annual balance sheet for Redx Pharma, fiscal year end - September 30th, GBP millions except per share, conversion factor applied.
R2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 3.7 | 27.5 | 29.6 | 53.9 | 18.1 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2.1 | 0.431 | 3.48 | 0.947 | 0.632 |
| Prepaid Expenses | |||||
| Total Current Assets | 5.81 | 29.5 | 35.8 | 59.4 | 23.3 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3.65 | 3.05 | 3.33 | 2.7 | 1.94 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Total Assets | 9.87 | 32.9 | 39.5 | 62.5 | 25.6 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4.67 | 10.9 | 9.59 | 27.2 | 21 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 8.38 | 30.9 | 26.4 | 29.2 | 22.3 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 1.49 | 2.03 | 13.1 | 33.3 | 3.35 |
| Total Liabilities & Shareholders' Equity | 9.87 | 32.9 | 39.5 | 62.5 | 25.6 |
| Total Common Shares Outstanding |